Last updated: 11/07/2018 17:08:19
A multi-centre, randomised, double blind, placebo controlled, parallel group study examining the effect of fluticasone propionate aqueous nasal spray (200mcg od) and/or inhaled fluticasone propionate (250mcg bd) in pollen induced asthma and rhinits.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A multi-centre, randomised, double blind, placebo controlled, parallel group study examining the effect of fluticasone propionate aqueous nasal spray (200mcg od) and/or inhaled fluticasone propionate (250mcg bd) in pollen induced asthma and rhinits.
Trial description: A multi-centre, randomised, double blind, placebo controlled, parallel group study examining the effect of fluticasone propionate aqueous nasal spray (200mcg od) and/or inhaled fluticasone propionate (250mcg bd) in pollen induced asthma and rhinits.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Dahl R, Baker R C, and Pauwels R . Abstract: seasonal rhinitis and asthma: effects of topical nasal and/or orally inhaled fluticasone propionate - the spira study (fnm40001). American Academy of Allergy, Asthma and Immunology 57th Annual Meeting 3/16/2001 New Orleans, LA; USA
Medical condition
Rhinitis, Allergic, Seasonal
Product
fluticasone propionate
Collaborators
Not applicable
Study date(s)
March 1998 to July 1999
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1999-31-07
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website